文章摘要

体外反搏治疗对不稳定型心绞痛患者心功能、血小板活化及血管内皮依赖的舒缩功能的影响

作者: 1尚福顺, 1史宏伟, 1孙春丽, 1王丽媛
1 秦皇岛市工人医院心内科,河北 秦皇岛 066200
通讯: 尚福顺 Email: sfsly514@163.com
DOI: 10.3978/j.issn.2095-6959.2022.08.021
基金: 秦皇岛市重点研究计划科技支撑项目(201902A060)。

摘要

目的:探讨体外反搏(external counter pulsation,ECP)治疗不稳定型心绞痛(unstable angina,UA)对患者心功能、血小板活化及血管内皮依赖的舒缩功能的影响。方法:选取2018年7月至2021年5月秦皇岛市工人医院收治的冠心病UA患者106例,随机分为对照组与观察组,每组53例。其中对照组给予常规西药治疗,观察组在对照组的基础上给予ECP治疗,对比两组临床疗效、心功能、血小板活化、血管内皮依赖的舒缩功能指标变化情况及安全性。结果:观察组与对照组总有效率分别为94.34%和81.13%,差异有统计学意义(P<0.05)。治疗后,观察组左心室射血分数(left ventricular ejection fraction,LVEF)、每搏输出量(stroke volume,SV)、心排量(cardiac output,CO)均显著高于对照组(均P<0.05),左心室舒张末期内径(left ventricular end diastolic diameter,LVEDD)显著低于对照组(P<0.05)。治疗后,观察组血小板微粒(platelet microparticles,PMPs)表面膜糖蛋白(CD62p、CD63)、活化血小板糖基化复合物(glycopropean complex of activated platelets,PAC-1)及溶血磷脂酸(lysophosphatidic acid,LPA)表达水平及血清内皮素-1(endothelin-1,ET-1)含量均显著低于对照组(均P<0.05),血清一氧化氮(nitric oxide,NO)含量显著高于对照组(P<0.05)。治疗期间,两组均未出现严重不良反应。结论:ECP辅助治疗UA可以提高患者心功能,其机制可能与改善血小板活化及血管内皮依赖的舒缩功能有关。
关键词: 体外反搏;不稳定型心绞痛;心功能;康复治疗

Effects of external counter pulsation on cardiac function, platelet activation, and endothelial dependent vasomotor function in patients with unstable angina

Authors: 1SHANG Fushun, 1SHI Hongwei, 1SUN Chunli, 1WANG Liyuan
1 Department of Cardiology, Qinhuangdao Workers’ Hospital, Qinhuangdao Hebei 066200, China

CorrespondingAuthor: SHANG Fushun Email: sfsly514@163.com

DOI: 10.3978/j.issn.2095-6959.2022.08.021

Foundation: This work was supported by the Qinhuangdao Key Research Program of Science and Technology Support Project, China (201902A060).

Abstract

Objective: To investigate the effects of external counter pulsation (ECP) on cardiac function, platelet activation, and endothelial dependent vasomotor function in patients with unstable angina (UA). Methods: A total of 106 patients with UA admitted to Qinhuangdao Workers’ Hospital from July 2018 to May 2021 were selected and randomly divided into 2 groups, with 53 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with ECP on the basis of the control group. The clinical efficacy, cardiac function, platelet activation, endothelial dependent vasomotor function, and safety of the 2 groups were compared. Results: The total effective rates of the observation group and the control group were 94.34% and 81.13%, respectively, with significant difference (P<0.05). After the treatment, the left ventricular ejection fraction (LVEF), stroke volume (SV), and cardiac output (CO) in the observation group were significantly higher than those in the control group (all P<0.05), and left ventricular end-diastolic diameter (LVEDD) was significantly lower than that in the control group (P<0.05). After the treatment, the expression levels of platelet microparticles (PMPs) surface membrane glycoprotein (CD62p, CD63), glycopropean complex of activated platelets (PAC-1) and lysophosphatidic acid (LPA), and the content of serum endothelin-1 (ET-1) in the observation group were significantly lower than those in the control group (all P<0.05), and the content of serum nitric oxide (NO) was significantly higher than that in the control group (P<0.05). During the treatment, no serious adverse reactions occurred in the 2 groups. Conclusion: ECP adjuvant treatment of UA can improve cardiac function of patients, and its mechanism may be related to the improvement of platelet activation and endothelial dependent vasomotor function.

Keywords: external counter pulsation; unstable angina; cardiac function; rehabilitation treatment

文章选项